Learn why cord blood may be an excellent starting material for your therapy
Cord blood has been used to provide life-saving treatments to patients for decades, but its full potential has not yet been tapped.
During this hour long on-demand webinar, our panelists discuss:
- Why it’s essential to have a good understanding of critical starting material attributes and how this may impact your cord blood starting material supply
- How and why cord blood is a valuable starting material for emerging cell therapies
- How sourcing cord blood units from multiple banks is critical to achieve supply scalability and sustainability
- Why alignment on necessary banking practice updates will ensure scalable supply and facilitate future cord blood use
PANELISTS
Joy Aho, PhD
Director, Product Management
NMDP BioTherapies℠
Wouter van’t Hof, PhD
Director, Cord Blood Bank & CEO, Cleveland Cell Therapy Incubator
Cleveland Cord Blood Center
Ann Kaestner
CCBB Associate Director
Carolinas Cord Blood Bank